Elusys Therapeutics Inc Fka Nighthawk Biosciences, Inc.
Lobbying group · Jul 2025 – Sep 2026
Elusys Therapeutics Inc Fka Nighthawk Biosciences, Inc. spent $850K lobbying the federal government (Jul 2025 – Sep 2026), mostly on defense, health care.
- Spent on lobbying
- $850K
- Bills lobbied
- 11
- Issues
- 2
Spending by quarter
- 2025 Q3$150K
- 2025 Q4$200K
- 2026 Q1$220K
- 2026 Q2$280K
Issues lobbied
- Defense
- Health care
Bills lobbied on
- H.R. 2707: Protecting American Families and Servicemembers from Anthrax Act4 reports
- S. 25873 reports
- H.R. 3838: SPEED Act3 reports
- S. 2572: Department of Defense Appropriations Act, 20262 reports
- H.R. 4016: Department of Defense Appropriations Act, 20262 reports
- H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies…2 reports
- H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies…1 report
- H.R. 9010: Making appropriations for the Legislative Branch for the fiscal year ending September…1 report
- H.R. 8800: National Defense Authorization Act for Fiscal Year 20271 report
- S. 4784: National Defense Authorization Act for Fiscal Year 20271 report
- H.R. 9495: Department of Defense Appropriations Act, 20271 report
Lobbying firms hired
- Elusys Therapeutics Inc Fka Nighthawk Biosciences, Inc.$850K
Agencies contacted
- Defense, Dept of (Dod) · 8
- Health & Human Services, Dept of (Hhs) · 8
- House Of Representatives · 8
- Natl Security Council (Nsc) · 8
- Office of Science & Technology Policy (Ostp) · 8
- Senate · 8
Related
Filings
- 2026 Q2 report$280K
- 2026 Q1 report$220K
- 2025 Q4 report$200K
- 2025 Q3 report$150K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Elusys Therapeutics Inc Fka Nighthawk Biosciences, Inc.: Lobbying…,” https://www.capitolreceipts.com/lobbying/celusystherapeuticsfkanighthawkbiosciences/elusys-therapeutics-inc-fka-nighthawk-biosciences-inc (accessed 2026-10-17).